C. D. , Emergency department visits after use of a drug sold as "bath salts"--Michigan, vol.60, pp.624-627, 2010.

M. Coppola and R. Mondola, Synthetic cathinones: chemistry, pharmacology and toxicology of a new class of designer drugs of abuse marketed as "bath salts" or "plant food, Toxicol. Lett, vol.211, pp.144-149, 2012.

O. Corazza, F. Schifano, M. Farre, P. Deluca, Z. Davey et al., Designer drugs on the internet: a phenomenon out-of-control? the emergence of hallucinogenic drug Bromo-Dragonfly, Curr. Clin. Pharmacol, vol.6, pp.125-129, 2011.

S. David, M. Bournot, F. Lelièvre, and A. Tallec, Consommation de drogues illicites chez les jeunes des Pays de la Loire, 2011.

V. Dumestre-toulet and A. Verstraete, Chapitre 4 -Toxicologie et Internet, Traité de Toxicologie Médico-Judiciare, 2012.

S. Elz, T. Kläs, U. Warnke, and H. Pertz, Development of highly potent partial agonists and chiral antagonists as tool for the study of 5-HT2A-receptor mediated function, Naunyn-Schmiedebergs Arch. Pharmacol. R29, 2002.

M. B. Forrester, Synthetic cathinone exposures reported to Texas poison centers, Am. J. Drug Alcohol Abuse, vol.38, pp.609-615, 2012.

R. W. Freudenmann and M. Spitzer, The Neuropsychopharmacology and Toxicology of 3,4-methylenedioxy-N-ethyl-amphetamine (MDEA), CNS Drug Rev, vol.10, pp.89-116, 2004.

M. Ghysel-laporte, P. Sibille, and N. Milan, Amphétamines et dérivés, Traité de Toxicologie Médicojudiciaire, 2012.

E. Gouzoulis-mayfrank, Differential actions of an entactogen compared to a stimulant and a hallucinogen in healthy humans, 2001.

M. Guillaume and G. Pavic, Phénomènes émergents liés aux drogues en 2010. Tendances récentes sur le site de Rennes, 2011.

R. Heim, Synthese und Pharmakologie potenter 5-HT2A-Rezeptoragonisten mit N-2-Methoxybenzyl-Partialstruktur, 2003.

C. Hernandez-lopez, M. Farre, P. N. Roset, E. Menoyo, N. Pizarro et al., 4-Methylenedioxymethamphetamine (ecstasy) and alcohol interactions in humans: psychomotor performance, subjective effects, vol.3, 2002.

, J. Pharmacol. Exp. Ther, vol.300, pp.236-244

S. L. Hill, T. Doris, S. Gurung, S. Katebe, A. Lomas et al., Severe clinical toxicity associated with analytically confirmed recreational use of 25I-NBOMe: case series, Clin. Toxicol, vol.51, pp.487-492, 2013.

S. L. Hill and S. H. Thomas, Clinical toxicology of newer recreational drugs, Clin. Toxicol. (Phila.), vol.49, pp.705-719, 2011.

J. P. Kelly, Cathinone derivatives: a review of their chemistry, pharmacology and toxicology, Drug Test Anal, vol.3, pp.439-453, 2011.

E. Lahaie, M. Martinez, and A. Cadet-taïrou, Nouveaux produits de synthèse et Internet, 2013.

M. E. Liechti, I. Kunz, and H. Kupferschmidt, Acute medical problems due to Ecstasy use. Case-series of emergency department visits, Swiss Med. Wkly, vol.135, pp.652-657, 2005.

S. S. Martins, G. Mazzotti, and H. D. Chilcoat, Trends in ecstasy use in the United States from 1995 to 2001: comparison with marijuana users and association with other drug use, Exp. Clin. Psychopharmacol, vol.13, pp.244-52, 2005.

H. H. Maurer, Chemistry, pharmacology, and metabolism of emerging drugs of abuse, Ther. Drug Monit, vol.32, pp.544-549, 2010.

C. M. Milroy, Ecstasy" associated deaths: what is a fatal concentration? Analysis of a case series, Forensic Sci. Med. Pathol, vol.7, pp.248-252, 2011.

W. M. Mohamed, S. Ben-hamida, J. C. Cassel, A. P. De-vasconcelos, and B. C. Jones, MDMA: interactions with other psychoactive drugs, Pharmacol. Biochem. Behav, vol.99, pp.759-774, 2011.

J. M. Pearson, T. L. Hargraves, L. S. Hair, C. J. Massucci, C. C. Frazee et al., Three fatal intoxications due to methylone, J. Anal. Toxicol, vol.36, pp.444-451, 2012.

H. E. Persson, G. K. Sjoberg, J. A. Haines, and J. Pronczuk-de-garbino, Poisoning severity score. Grading of acute poisoning, J. Toxicol. Clin. Toxicol, vol.36, pp.205-213, 1998.

, Psychonaut Web Mapping Project: Final report. Institute of Psychiatry, King's College London, 2010.

A. Shulgin, Pihkal: A Chemical Love Story, 1991.